Poly Medicure Ltd.
Snapshot View

883.40 +27.85 ▲3.3%

31 January 2023, 12:57:58 PM
Volume: 17,786

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.polymedicure.com
Market Cap 8,291.38 Cr.
Enterprise Value(EV) 8,588.35 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 16.32 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 52.93 Trailing Twelve Months Ending 2022-12
Industry PE 54.40 Trailing Twelve Months Ending 2022-12
Book Value / Share 125.57 Trailing Twelve Months Ending 2022-12
Price to Book Value 6.88 Calculated using Price: 863.95
Dividend Yield 0.29 Period Ending 2022-03
No. of Shares Subscribed 9.60 Cr. 95,970,592 Shares
FaceValue 5
Company Profile
Poly Medicure Ltd. was conceived and established by a group of engineers and technocrats dedicated to the idea of providing the benefits of modern healthcare to the mankind at affordable price. This unique philosophy has been the driving force behind the company since its inception in 1995. Today it has grown into one of the most dynamically versatile manufacturers of disposable healthcare products in the region with over 60 different products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+3.26%
1 Week
+2.32%
1 Month
-1.61%
3 Month
-4.12%
6 Month
+20.97%
1 Year
-1.96%
2 Year
+74.40%
5 Year
+253.43%
10 Year
+1408.54%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 34.10 36.03 22.35 21.81 22.76 17.80 22.98 19.42 14.29
Return on Capital Employed (%) 38.77 38.90 25.59 24.37 25.39 22.19 24.43 21.96 17.42
Return on Assets (%) 17.59 18.97 12.64 12.92 13.58 10.27 12.66 13.15 11.08

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 146 196 229 272 338 381 435 966 1,087 1,134
Non Curr. Liab. 51 55 49 72 104 119 139 87 63 49
Curr. Liab. 89 113 109 114 123 181 225 215 227 265
Minority Int.
Equity & Liab. 286 364 387 457 565 682 800 1,267 1,377 1,448
Non Curr. Assets 166 205 217 252 310 352 450 520 593 665
Curr. Assets 120 160 171 205 255 329 350 748 783 784
Misc. Exp. not W/O
Total Assets 286 364 387 457 565 682 800 1,267 1,377 1,448

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 322 390 412 455 520 611 687 786 923 1,066
Other Income 1 8 8 14 14 18 18 18 38 36
Total Income 323 398 421 469 535 629 706 805 961 1,102
Total Expenditure -247 -304 -325 -362 -398 -480 -521 -570 -708 -828
PBIDT 77 94 96 107 136 150 185 235 253 274
Interest -9 -10 -10 -9 -12 -14 -20 -11 -6 -8
Depreciation -14 -19 -21 -24 -29 -37 -41 -48 -54 -56
Taxation -19 -23 -18 -20 -26 -35 -30 -44 -49 -54
Exceptional Items 10 20
PAT 44 62 47 55 69 64 94 136 147 155
Minority Interest
Share Associate 1 1 1 1 1 1 2 2
Other Related Items
Consolidated Net Profit 45 62 48 55 71 65 96 136 147 157
Adjusted EPS 5 7 5 6 8 7 11 14 15 16

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 39 66 63 63 56 75 106 128 119 123
Cash Fr. Inv. -31 -58 -59 -31 -56 -88 -101 -107 -436 -85
Cash Fr. Finan. -8 5 -6 -31 0 16 -5 -21 317 -35
Net Change 0 13 -2 1 0 3 1 1 0 3
Cash & Cash Eqvt 1 14 12 13 1 4 4 5 5 8

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 48.77 44.88 44.77 44.77 44.76 44.66 53.34 53.33 53.33
Public 51.23 55.12 55.23 55.23 55.24 55.34 46.66 46.67 46.67
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 27 Jan 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Poly Medicure Limited has informed the Exchange about Schedule of meet
Thu, 17 Nov 2022
Related Party Transaction
Poly Medicure Limited has informed the Exchange about related party transaction for the period ended September 2022
Wed, 16 Nov 2022
Related Party Transaction
Poly Medicure Limited has informed the Exchange about related party transaction for the period ended September 2022

Technical Scans View Details >>

Mon, 30 Jan 2023
Higher Trade Quantity Higher Trade Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Low Close Crossing Last Month Low
Closing Below Previous Low Closing Below Previous Low
Close Below Last Week Low Close Below Last Week Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 252,338.06 1,035.00 -1.6%
Divi's Laboratories Ltd. 89,367.34 3,342.15 -0.7%
Cipla Ltd. 83,741.18 1,026.60 -0.8%
Dr. Reddy's Laboratories Ltd. 72,084.75 4,332.60 +0.1%
Apollo Hospitals Enterprise Ltd. 61,094.10 4,298.30 +1.4%
Torrent Pharmaceuticals Ltd. 52,291.51 1,524.20 -1.5%
Abbott India Ltd. 44,555.01 20,890.00 -0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 61.43 1,035.00 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-09 29.89 3,342.15 -0.7%
Cipla Ltd. Consolidated 2022-12 31.74 1,026.60 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.79 4,332.60 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.76 4,298.30 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.93 1,524.20 -1.5%
Abbott India Ltd. Standalone 2022-09 50.53 20,890.00 -0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.75 1,035.00 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,342.15 -0.7%
Cipla Ltd. Consolidated 2022-12 3.69 1,026.60 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.28 4,332.60 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.21 4,298.30 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,524.20 -1.5%
Abbott India Ltd. Standalone 2022-09 16.41 20,890.00 -0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,035.00 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.15 -0.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.60 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,332.60 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,298.30 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,524.20 -1.5%
Abbott India Ltd. Standalone 2022-03 0.00 20,890.00 -0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,035.00 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.15 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.60 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,332.60 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,298.30 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,524.20 -1.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,890.00 -0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,035.00 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.15 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.60 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,332.60 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,298.30 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,524.20 -1.5%
Abbott India Ltd. Standalone 2022-03 29.95 20,890.00 -0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,035.00 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.15 -0.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.60 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,332.60 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,298.30 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,524.20 -1.5%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,890.00 -0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,035.00 -1.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.15 -0.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.60 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,332.60 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,298.30 +1.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,524.20 -1.5%
Abbott India Ltd. Standalone 2022-03 798.70 20,890.00 -0.5%

FAQ's On Poly Medicure Ltd.

What is Poly Medicure share price?

Can I buy Poly Medicure shares now?

What is the Dividend Yield of Poly Medicure?

What is the Market Cap of Poly Medicure?

What are the key metrics to analyse Poly Medicure?

What is the 52 Week High and Low of Poly Medicure?

What is the trend of Poly Medicure share price?